You are now viewing our public site. Back to Dashboard

Hormonal Adjuvant Therapy and Its Impact on Function

presented by Nicole L. Stout, DPT, CLT-LANA, FAPTA

Accrediting Body:

Target Audience:

Levels:
Disclosure Statement:

Financial — Nicole Stout is a Key Opinion Consultant: BSN Medical Consultant to the National Institutes of Health, Rehabilitation Medicine Department* Consultant to Survivorship Solutions LLC Nonfinancial — Chair, Oncology Specialty Council of the American Board of Physical Therapy Specialties

Satisfactory completion requirements: All disciplines must complete learning assessments to be awarded credit, no minimum score required unless otherwise specified within the course.

MedBridge is committed to accessibility for all of our subscribers. If you are in need of a disability-related accommodation, please contact [email protected]. We will process requests for reasonable accommodation and will provide reasonable accommodations where appropriate, in a prompt and efficient manner.

Accreditation Check:
Video Runtime: 66 Minutes; Learning Assessment Time: 29 Minutes

The most prevalent cancers in the United States today, breast and prostate, are commonly treated with a long-term regimen of hormonal drug agents proven to reduce the growth of cancer cells and reduce the risk of disease recurrence. These drug agents also incite significant interactions systemically that contribute to a high rate of functional impairment including bone density loss, pain, increased adiposity, and reduced lean mass in these patients. Guidelines for hormonal therapies recommend treatment for 3-5 years post completion of cancer treatment. The protracted timeline for treatment and the aggregate burden of these side effects increase the risk for long-term disability and frailty in cancer survivors and warrant specific rehabilitative interventions to mitigate their impact.

Meet Your Instructor

Nicole L. Stout, DPT, CLT-LANA, FAPTA

Dr. Nicole L. Stout is a research assistant professor in the School of Medicine, Department of Hematology/Oncology at West Virginia University Cancer Institute and with the School of Public Health, Department of Health Policy, Management, and Leadership. She also serves as the associate director of the WVU Cancer Institute's Survivorship Program, where she coordinates the…

Read full bio

Chapters & Learning Objectives

Download Learning Objectives Download Learning Objectives

Enter your information to unlock the learning objectives.

Thank you!

Download the learning objectives for Hormonal Adjuvant Therapy and Its Impact on Function.

Download Learning Objectives

1. Classes of Hormonal Agents and Their Use in Cancer Treatment

In some types of cancers, cell growth can be accelerated by the presence of sex hormones. Hormone receptors are present on a majority of breast and prostate cancer cells. Adjuvant hormonal agents provide a mechanism to suppress tumor growth by reducing the impact of circulating hormones on the cancer cells.

2. Breast-Cancer-Related Hormonal Therapies: Side Effects and Clinical Management of Impairments

Specific drug classes are used to reduce the impact of estrogen and progesterone on breast cancer cell growth. These drugs, however, reduce the overall impact of hormones systemically and lead to metabolic and endocrine changes, joint arthralgias, weight gain, and loss of bone density. Rehabilitation interventions can minimize the severity of these side effects and their impact on function.

3. Prostate-Cancer-Related Hormonal Therapies: Side Effects and Clinical Management of Impairments

Specific drug classes are used to reduce the impact of androgen and testosterone on prostate cancer cell growth. These drugs, however, reduce the overall impact of hormones systemically and lead to metabolic and endocrine changes, reduced lean mass, and loss of bone density, and negatively impact libido. Rehabilitation interventions can minimize the severity of these side effects and their impact on function.

4. Considerations for Rehabilitation Interventions

The duration of hormonal therapy use is protracted, often over the course of several years, and side effects may be intermittent in onset or progressive over time. Consideration for screening and assessment of emerging impairment, mitigating the functional impact of these known side effects, and promoting evidence-based interventions can guide the rehabilitation plan of care and optimize function.

Sign up to get free evidence-based articles, exclusive discounts, and insights from industry-leaders.

Join our newsletter to get the latest updates delivered straight to your inbox.

MedBridge blog posts and emails

Request a Demo

For groups of 5 or more, request a demo to learn about our solution and pricing for your organization. For other questions or support, visit our contact page.